The Pharma Data

NOVEMBER 9, 2020

Image: Copyright © 2009-2020 Merck Sharp & Dohme Corp., The trial looked at a combination of Keytruda from Merck and Lenvima from Eisai for the treatment of advanced renal cell carcinoma (RCC). Merck has been exploring Keytruda and ipilimumab as a first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC).

Research Laboratories 52

Research Laboratories Laboratories Treatment Therapies 52

Drug Target Review

SEPTEMBER 26, 2023

Indiplon is a marketed sleeping aid whose decreased activity was immediately reversed with application of the benzodiazepine site antagonist, flumazenil, a compound that is used clinically to reverse benzodiazepine overdose. 2009 Sep;14(17–18):876–84. Neurotoxicology. 2010 Aug;31(4):331–50. Drug Discov Today. Toxicol In Vitro.

Drugs 111

Drugs FDA Disease Animal Testing 111

Conversations in Drug Development Trends

FEBRUARY 22, 2023

Rare Disease Day on February 28th is a chance for rare disease communities to come together as one and join in conversation with stakeholders searching for treatments, raising money to support research, and changing the way healthcare and governments interact with patients.

Disease 52

Disease Clinical Trials Trials Treatment 52

The Pharma Data

NOVEMBER 17, 2020

In 2009 Tony took on the challenge of a new start up in San Antonio at RMATX that has grown to 2 IVF centers and 2 satellite centers. program that increases access to care for patients needing advanced fertility treatment that has drawn patients to her practice from across the country who have deemed her Fertility Fairy Godmother. .

Laboratories 52

Laboratories Nurses Doctors International 52

The Pharma Data

NOVEMBER 11, 2020

managing partner and director of clinical research, Sierra Eye Associates, clinical associate professor of ophthalmology, University of Nevada Presentation date and time: The pre-recorded presentation containing slides and audio will be available to AAO 2020 Virtual attendees starting on Wednesday, November 11.

Science 40

Science Treatment Disease Engineering 40

The Pharma Data

DECEMBER 7, 2020

based clinical trials investigating interventions for high blood pressure between 2009-2018, just 52 were exclusively in Black people. While the numbers grew over that decade – from 3.9% (3 of 77 trials) in 2009 to 6.2% (9 of 146) in 2018 – the increase was not enough to be statistically significant.

Treatment 52

Treatment Clinical Trials Trials Doctors 52

The Pharma Data

JUNE 24, 2021

“By combining enzalutamide, which has a proven clinical benefit in men with metastatic castration-sensitive prostate cancer, with talazoparib, our PARP inhibitor that is active in DDR-mutated cancer, we may be able to offer a new treatment option that targets the underlying genetic mechanisms associated with DDR-mutated mCSPC.”.

Clinical Trials 52

Clinical Trials DNA Trials Treatment 52